iopamidol has been researched along with Disease Exacerbation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, Y; Harieaswar, S; Morgan, B; Rajesh, A; Tyagi, R | 1 |
| Diederich, S | 1 |
| Andreano, A; Laeseke, PF; Lee, FT; Livraghi, T; Meloni, MF; Sironi, S | 1 |
| de Greiff, A; Forsting, M; Kalkmann, J; Ladd, SC; Stattaus, J | 1 |
| Cohan, RH; Davenport, MS; Dillman, JR; Ellis, JH; Somashekar, DK | 1 |
| Allenberg, JR; Böckler, D; Geisbüsch, P; Hyhlik-Dürr, A; Kotelis, D; von Tengg-Kobligk, H | 1 |
6 other study(ies) available for iopamidol and Disease Exacerbation
| Article | Year |
|---|---|
Routine use of positive oral contrast material is not required for oncology patients undergoing follow-up multidetector CT.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Barium Sulfate; Contrast Media; Digestive System Neoplasms; Disease Progression; Female; Follow-Up Studies; Humans; Injections, Intravenous; Iopamidol; Male; Medical Audit; Middle Aged; Patient Satisfaction; Peritoneal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed; Urogenital Neoplasms; Young Adult | 2009 |
[Are oral contrast media required for follow-up assessments?].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Barium Sulfate; Contrast Media; Digestive System Neoplasms; Disease Progression; Female; Follow-Up Studies; Humans; Injections, Intravenous; Iopamidol; Male; Medical Audit; Middle Aged; Patient Satisfaction; Peritoneal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed; Urogenital Neoplasms; Young Adult | 2009 |
Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
Topics: Aged; Breast Neoplasms; Catheter Ablation; Contrast Media; Disease Progression; Female; Humans; Iopamidol; Liver Neoplasms; Middle Aged; Phospholipids; Proportional Hazards Models; Retrospective Studies; Sulfur Hexafluoride; Survival Rate; Treatment Outcome; Ultrasonography, Interventional | 2009 |
Suitability of semi-automated tumor response assessment of liver metastases using a dedicated software package.
Topics: Adult; Aged; Antineoplastic Agents; Artificial Intelligence; Colorectal Neoplasms; Contrast Media; Disease Progression; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Iopamidol; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Observer Variation; Radiology Information Systems; Sensitivity and Specificity; Software; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Effect of intravenous low-osmolality iodinated contrast media on patients with myasthenia gravis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Child; Child, Preschool; Contrast Media; Disease Progression; Female; Humans; Injections, Intravenous; Iohexol; Iopamidol; Male; Middle Aged; Myasthenia Gravis; Osmolar Concentration; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2013 |
Thoracic aortic endografting in patients with connective tissue diseases.
Topics: Adult; Age Factors; Aged; Angiography, Digital Subtraction; Aorta, Thoracic; Aortic Diseases; Blood Vessel Prosthesis Implantation; Contrast Media; Disease Progression; Ehlers-Danlos Syndrome; Female; Humans; Iopamidol; Male; Marfan Syndrome; Middle Aged; Postoperative Complications; Reoperation; Retrospective Studies; Stents; Treatment Outcome | 2008 |